Cargando…

Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies

OBJECTIVE: Protein phosphatase 2A (PP2A) is a heterotrimeric holoenzyme composed of a catalytic C subunit, a structural A subunit, and one of several regulatory B subunits that confer substrate specificity. The assembly and activity of PP2A are regulated by reversible methylation of the C subunit. α...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hye‐Jin, Lee, Kang‐Woo, Park, Eun S., Oh, Stephanie, Yan, Run, Zhang, Jie, Beach, Thomas G., Adler, Charles H., Voronkov, Michael, Braithwaite, Steven P., Stock, Jeffry B., Mouradian, M. Maral
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048387/ https://www.ncbi.nlm.nih.gov/pubmed/27752512 http://dx.doi.org/10.1002/acn3.337

Ejemplares similares

Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB
por: Yan, Run, et al.
Publicado: (2018)

Brainstem-Predominant Lewy-Related Pathology in a Patient with Parkinson’s Disease without Dementia
por: Choi, Ji-Hyun, et al.
Publicado: (2020)

The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress
por: Oh, Stephanie E., et al.
Publicado: (2018)

Dementia with Lewy Bodies versus Alzheimer's Disease and Parkinson's Disease Dementia: A Comparison of Cognitive Profiles
por: Park, Kyung Won, et al.
Publicado: (2011)

Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
por: Jellinger, Kurt A., et al.
Publicado: (2018)

Cortical thinning in dementia with Lewy bodies and Parkinson disease dementia
por: Colloby, Sean J, et al.
Publicado: (2019)

Relative survival in patients with dementia with Lewy bodies and Parkinson’s disease dementia
por: Larsson, Victoria, et al.
Publicado: (2018)

LRRK2 in Parkinson's disease and dementia with Lewy bodies
por: Zhu, Xiongwei, et al.
Publicado: (2006)

Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies
por: Pagan, Fernando, et al.
Publicado: (2016)

Resting state in Parkinson's disease dementia and dementia with Lewy bodies: commonalities and differences
por: Peraza, Luis R., et al.
Publicado: (2015)

Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies
por: Weil, Rimona S., et al.
Publicado: (2017)

Parkinson’s Disease Dementia and Dementia with Lewy Bodies Have Similar Neuropsychological Profiles
por: Aldridge, Georgina M., et al.
Publicado: (2018)

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
por: Schulz-Schaeffer, Walter J.
Publicado: (2010)

Analysis of the Substantia Innominata Volume in Patients with Parkinson’s Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer’s Disease
por: Kim, Hee Jin, et al.
Publicado: (2011)

Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease
por: Su, Bo, et al.
Publicado: (2009)

The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia
por: Stubendorff, Kajsa, et al.
Publicado: (2012)

Clinical and Neuropsychological Differences between Mild Parkinson's Disease Dementia and Dementia with Lewy Bodies
por: Petrova, Mariya, et al.
Publicado: (2015)

(18)F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
por: Smith, Ruben, et al.
Publicado: (2018)

Effects of carbonated liquid on swallowing dysfunction in dementia with Lewy bodies and Parkinson’s disease dementia
por: Larsson, Victoria, et al.
Publicado: (2017)

Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis
por: Meng, Yan-Hong, et al.
Publicado: (2019)

Goal Setting for Cognitive Rehabilitation in Mild to Moderate Parkinson's Disease Dementia and Dementia with Lewy Bodies
por: Watermeyer, Tamlyn J., et al.
Publicado: (2016)

Different Clinical and Neuroimaging Characteristics in Early Stage Parkinson’s Disease with Dementia and Dementia with Lewy Bodies
por: Takemoto, Mami, et al.
Publicado: (2016)

CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
por: Bibl, Mirko, et al.
Publicado: (2006)

An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias
por: Datta, Arnab, et al.
Publicado: (2017)

Cytoprotective mechanisms of DJ-1 against oxidative stress through modulating ERK1/2 and ASK1 signal transduction
por: Oh, Stephanie E., et al.
Publicado: (2017)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
por: Chiasserini, Davide, et al.
Publicado: (2015)

Fatal Familial Insomnia Initially Developing Parkinsonism Mimicking Dementia with Lewy Bodies
por: Fukuoka, Takuya, et al.
Publicado: (2018)

Regional Structural Hippocampal Differences Between Dementia with Lewy Bodies and Parkinson’s Disease
por: de Schipper, Laura J., et al.
Publicado: (2019)

Cortical connectivity of the nucleus basalis of Meynert in Parkinson’s disease and Lewy body dementias
por: Oswal, Ashwini, et al.
Publicado: (2020)

Dopaminergic Dysfunction Is More Symmetric in Dementia with Lewy Bodies Compared to Parkinson’s Disease
por: Fedorova, Tatyana Dmitrievna, et al.
Publicado: (2023)

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study
por: Stubendorff, Kajsa, et al.
Publicado: (2014)

Reduced vascular risk factors in Parkinson's disease dementia and dementia with Lewy bodies compared to Alzheimer's disease
por: Chan, Po‐Chi, et al.
Publicado: (2018)

Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer’s disease dementia
por: Beach, Thomas G., et al.
Publicado: (2020)

Increased expression of pathological markers in Parkinson’s disease dementia post-mortem brains compared to dementia with Lewy bodies
por: Tu, Haitao, et al.
Publicado: (2022)

Identification of key genes and signaling pathways associated with dementia with Lewy bodies and Parkinson's disease dementia using bioinformatics
por: Xu, Jing, et al.
Publicado: (2023)

Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases
por: Guerreiro, Rita, et al.
Publicado: (2016)

Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson’s disease and Lewy body dementia
por: Asghar, Muhammad, et al.
Publicado: (2022)

Melanin: a unifying theory of disease as exemplified by Parkinson’s, Alzheimer’s, and Lewy body dementia
por: Berg, Stacie Z., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u8sno70qqk6hl2oc1me7tgmn64